Healthcare company Heidi has completed a Series B funding round, raising $65m to build an AI care partner for every clinician.
The round was headed by Point72 Private Investments, with support from existing investors Latitude, Blackbird and Headline.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The AI care partner assists clinicians by automating tasks such as follow-up communications, clinical documentation and evidence searches.
Heidi CEO and co-founder Dr Thomas Kelly said: “It is untenable that healthcare demand continues to rise while clinical time continues to shrink. Building a sustainable healthcare system requires expanding clinical capacity without compromising clinician wellbeing or patient safety.
“That’s why I founded Heidi: to build an AI care partner that stands alongside clinicians, empowering them to deliver the care to which they have dedicated their lives.”
More than 200 medical specialities have utilised Heidi to alleviate administrative burdens.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHeidi has facilitated 73 million patient consultations since April 2024 and currently supports more than two million consultations each week in 110 languages across 116 countries.
The company will also expand its office locations and local support in the UK, Canadian and US markets while building on clinician-led adoption in France, Germany, Hong Kong, Ireland, Singapore South Africa and Spain.
Point72 Private Investments managing partner Chandrasekar stated: “We believe administrative burden is contributing to clinician burnout and capacity challenges across healthcare systems.
“Heidi’s platform has the potential to meaningfully improve how clinicians manage their administrative workflows.”
As part of the funding round, Heidi announced Paul Williamson’s appointment as chief revenue officer along with that of Dr Simon Kos as chief medical officer.
